BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28789648)

  • 1. Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment).
    Fernandes J; Bregman B; Combemale P; Amaz C; de Léotoing L; Vainchtock A; Gaudin AF
    BMC Health Serv Res; 2017 Aug; 17(1):542. PubMed ID: 28789648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013.
    Maroun R; Maunoury F; Benjamin L; Nachbaur G; Durand-Zaleski I
    PLoS One; 2016; 11(9):e0162864. PubMed ID: 27649305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital burden of pulmonary arterial hypertension in France.
    Bergot E; De Leotoing L; Bendjenana H; Tournier C; Vainchtock A; Nachbaur G; Humbert M
    PLoS One; 2019; 14(9):e0221211. PubMed ID: 31536491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
    Chevalier J; Bonastre J; Avril MF
    Melanoma Res; 2008 Feb; 18(1):40-6. PubMed ID: 18227707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of dengue in three French territories of the Americas: an analysis of the hospital medical information system (PMSI) database.
    Uhart M; Blein C; L'Azou M; Thomas L; Durand L
    Eur J Health Econ; 2016 May; 17(4):497-503. PubMed ID: 25962729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
    Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
    Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort.
    Kandel M; Allayous C; Dalle S; Mortier L; Dalac S; Dutriaux C; Leccia MT; Guillot B; Saiag P; Lacour JP; Legoupil D; Lesimple T; Aubin F; Beylot-Barry M; Brunet-Possenti F; Arnault JP; Granel-Brocard F; Stoebner PE; Dupuy A; Maubec E; Grob JJ; Dreno B; Rotolo F; Ballon A; Michiels S; Lebbe C; Borget I
    Eur J Cancer; 2018 Dec; 105():33-40. PubMed ID: 30384014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment patterns and outcomes in patients with advanced melanoma in France.
    Bedane C; Leccia MT; Sassolas B; Bregman B; Lebbé C;
    Curr Med Res Opin; 2013 Oct; 29(10):1297-305. PubMed ID: 23808961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
    Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
    Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of osteoporosis in women: data from the 2008 French hospital database (PMSI).
    Maravic M; Jouaneton B; Vainchtock A; Tochon V
    Clin Exp Rheumatol; 2012; 30(2):222-7. PubMed ID: 22546070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study).
    McArthur GA; Mohr P; Ascierto PA; Arance A; Banos Hernaez A; Kaskel P; Weichenthal M; Shinde R; Stevinson K
    Oncologist; 2017 Aug; 22(8):951-962. PubMed ID: 28526721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012 (The HEPC-LONE study).
    Abergel A; Rotily M; Branchoux S; Akremi R; de Léotoing L; Vainchtock A; Gaudin AF
    Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):340-348. PubMed ID: 26546175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use and cost of antiretrovirals in France 1995-2000: an analysis based on the Medical Dossier on Human Immunodeficiency (release 2) database.
    Flori YA; le Vaillant M
    Pharmacoeconomics; 2004; 22(16):1061-70. PubMed ID: 15524494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in France.
    de Zelicourt M; Dardennes R; Verdoux H; Gandhi G; Khoshnood B; Chomette E; Papatheodorou ML; Edgell ET; Even C; Fagnani F
    Pharmacoeconomics; 2003; 21(15):1081-90. PubMed ID: 14596627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inpatient costs of endophthalmitis evaluated for the whole of France.
    Colin X; Berdeaux G; Lafuma A; Salvanet-Bouchara A; Kodjikian L
    Appl Health Econ Health Policy; 2010; 8(1):53-60. PubMed ID: 20038193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database.
    Weil-Olivier C; Taha MK; Emery C; Bouée S; Beck E; Aris E; Loncle-Provot V; Nachbaur G; Pribil C
    Infect Dis Ther; 2021 Sep; 10(3):1607-1623. PubMed ID: 34170505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database.
    St Guily JL; Borget I; Vainchtock A; Rémy V; Takizawa C
    Head Neck Oncol; 2010 Sep; 2():22. PubMed ID: 20809978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare usage and economic impact of non-treated obesity in Italy: findings from a retrospective administrative and clinical database analysis.
    Colao A; Lucchese M; D'Adamo M; Savastano S; Facchiano E; Veronesi C; Blini V; Degli Esposti L; Sbraccia P
    BMJ Open; 2017 Feb; 7(2):e013899. PubMed ID: 28237961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs associated with hospitalization in HIV-positive patients in France.
    de Léotoing L; Yazdanpanah Y; Finkielsztejn L; Chaize G; Vainchtock A; Nachbaur G; Aubin C; Bonnet F
    AIDS; 2018 Sep; 32(14):2059-2066. PubMed ID: 29894390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic venous insufficiency: the effects of health-care reforms on the cost of treatment and hospitalisation--an Italian perspective.
    Allegra C
    Curr Med Res Opin; 2003; 19(8):761-9. PubMed ID: 14687448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.